Sarcoidosis is unlike other granulomatous disorders in that the cause of the disease remains poorly understood. This session will present recent progress in the field of sarcoidosis, including exciting data from novel disease models and new scientific research platforms that are rapidly advancing our understanding of the disease, and could lead to new biomarkers and therapeutic targets to improve the care of sarcoidosis patients.